food and drug administration spokesman jeff nesbit said 0 the agency has turned over evidence in a criminal investigation concerning vitarine pharmaceuticals inc. to the u.s. attorney 's office in baltimore . neither vitarine nor any of the springfield gardens , n.y. , company 's officials or employees have been charged with any crimes . vitarine won approval to market a version of a blood pressure medicine but acknowledged that it substituted a smithkline beecham plc product as its own in tests . mr. nesbit also said 0 the fda has asked bolar pharmaceutical co. to recall at the retail level its urinary tract antibiotic . but so far the company has n't complied with that request , the spokesman said 0 . bolar , the subject of a criminal investigation by the fda and the inspector general 's office of the health and human services department , only agreed to recall two strengths of its version of macrodantin `` as far down as direct customers , mostly wholesalers , '' mr. nesbit said 0 . bolar , of copiague , n.y. , earlier began a voluntary recall of both its 100 milligram and 50 milligram versions of the drug . the fda has said 0 it presented evidence 0 it uncovered to the company indicating that bolar substituted the brand-name product for its own to gain government approval to sell generic versions of macrodantin . bolar has denied that it switched the brand-name product for its own in such testing .